Evidence map›Paper›PMID 32963063›Full record

ArticleBMJ open2020

Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial longitudinal follow-up protocol.

Danielle Mazza, Natalie Amos, Cathy J Watson, Kevin McGeechan, Marion Haas, Jeffrey F Peipert, Jayne Lucke, Angela Taft, Kathleen McNamee, Kirsten I Black

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Danielle MazzaDepartment of General Practice, Monash University, Melbourne, Victoria, Australia Danielle.Mazza@monash.edu.
Natalie AmosDepartment of General Practice, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0001-6558-2580
Cathy J WatsonDepartment of General Practice, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0002-2816-6956
Kevin McGeechanSchool of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Marion HaasCentre for Health Economics Research & Evaluation, University of Technology Sydney, Sydney, New South Wales, Australia.
Jeffrey F PeipertDepartment of Obstetrics & Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Jayne LuckeSchool of Psychology and Public Health, La Trobe University, Melbourne, Victoria, Australia.
Angela TaftJudith Lumley Centre, La Trobe University, Melbourne, Victoria, Australia.
Kathleen McNameeFamily Planning Victoria, Melbourne, Victoria, Australia.
Kirsten I BlackRoyal Prince Alfred Hospital, The University of Sydney, Sydney, New South Wales, Australia.
Monash University · AUThe University of Sydney · AUFamily Planning NSW · AUIndiana University School of MedicineLa Trobe University · AUThe University of Queensland · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThrough addressing main barriers to the uptake of long-acting reversible contraceptives (LARCs) among Australian women, the Australian Contraceptive ChOice pRoject (ACCORd) trialled an educational intervention targeting general practitioners (GPs) and provided those in the intervention group with a rapid referral service for quick insertion. The cluster randomised controlled trial resulted in greater uptake of LARC in the intervention group. This protocol paper describes a longitudinal follow-up to the ACCORd Study to assess the long-term efficacy and cost-effectiveness of the intervention. METHODS AND ANALYSIS: Women participants (patients of ACCORd GPs) completed a baseline, 6-month and 12-month survey. These participants will be invited to complete an additional follow-up survey 3 years post completion of their baseline interview. Based on the original ACCORd Study tools, the online survey will address long-term outcomes including contraceptive continuation rates and reproductive history, any unintended pregnancies, satisfaction and concerns with their current contraceptive method, and an assessment of quality of life. We will analyse data using binary regression models with generalised estimating equations and robust standard errors to account for clustering. DISCUSSION: Demonstration of sustained use, effectiveness at reducing unwanted pregnancies and cost-effectiveness of this strategy among this cohort of Australian primary care patients, will strengthen the policy and programme urgency of addressing wider dissemination of these strategies and replicating the study elsewhere. ETHICS AND DISSEMINATION: The ACCORd Study received approval from the Monash University Human Research Ethics Committee: CF16/188-201000080. Additionally, an amendment to conduct this 3-year longitudinal follow-up survey has been approved. The trial follow-up outcomes will be disseminated through formal academic pathways, including journal articles, national and international conferences and reports as well as using more 'mainstream' strategies such as seminars, workshops and media engagement. Additionally, outcomes will be communicated through policy briefs to Australian state and federal governments. TRAIL REGISTRATION NUMBER: This trial is registered with the Australian and New Zealand Trials Registry ACTRN12615001346561. Recruitment and data collection have been completed for the baseline, 6-month and 12-month surveys. Data collection for the 3-year survey commenced in August 2019.

Indexed as

General PracticeLong-Acting Reversible ContraceptionAustraliaFemaleFollow-Up StudiesHumansNew ZealandPregnancyQuality of LifeRandomized Controlled Trials as Topicpreventive medicineprimary carepublic healthreproductive medicine

Identifiers

PMID32963063
PMCPMC7509957
OpenAlexW3088946060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.